Results 241 to 250 of about 60,412 (320)

Clinical presentation, genotypic diversity, and intracellular bacteria in <i>Acanthamoeba</i> keratitis patients treated at a referral eye hospital in Sydney, Australia. [PDF]

open access: yesIJID Reg
Rayamajhee B   +10 more
europepmc   +1 more source

Study of fullerene C<sub>60</sub> effect on Escherichia coli in presence of antibiotics. [PDF]

open access: yesSci Rep
Moztarzadeh O   +4 more
europepmc   +1 more source

Genomic insights into extrapulmonary tuberculosis reveal enrichment of lineage 2 with high drug resistance in specific clinical phenotypes

open access: yes
Sharma K   +23 more
europepmc   +1 more source

Ofloxacin

open access: yesReactions Weekly, 2010
A fluoroquinolone antibacterial antibiotic. Ofloxacin binds to and inhibits bacterial topoisomerase II (DNA gyrase) and topoisomerase IV, enzymes involved in DNA replication and repair, resulting in cell death in sensitive bacterial species. (NCI04)
semanticscholar   +3 more sources
Some of the next articles are maybe not open access.

Related searches:

Ofloxacin

International Journal of Antimicrobial Agents, 1991
The fluoroquinolone antibiotic agents have been a major advance in the treatment of bacterial infections. The original quinolone nalidixic acid suffered from a narrow spectrum of activity and rapid development of drug resistance. The newer fluoroquinolones have more desirable properties including good oral absorption, enhanced antimicrobial activity ...
Y, Mouton, O, Leroy
  +8 more sources

Degradation of Ofloxacin by Perylene Diimide Supramolecular Nanofiber Sunlight-Driven Photocatalysis

Environmental Science & Technology, 2019
This study describes a promising sunlight-driven photocatalyst for the treatment of ofloxacin and other fluoroquinolone antibiotics in water and wastewater. Perylene diimide (PDI) supramolecular nanofibers, which absorb a broad spectrum of sunlight, were
Gang Yu, Lee M Blaney, Giovanni Cagnetta
exaly   +2 more sources

Home - About - Disclaimer - Privacy